Athina Stravodimou

6PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsToxicology (incl. clinical toxicology)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Feb 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|May 17, 2024
[Male breast cancer: a lesser-known battle].

Hinde Benchaa, Athina Stravodimou

|Jan 08, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.

Carole Bandiera, Isabella Locatelli, Perrine Courlet

|Jun 29, 2021
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.

Carole Bandiera, Evelina Cardoso, Isabella Locatelli

|Feb 22, 2021
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.

George Sflomos, Laura Battista, Patrick Aouad

Pageof 1

Frequent Collaborators

4 joint publications

Khalil Zaman

3 joint publications

Apostolos Sarivalasis

2 joint publications

George Sflomos

2 joint publications

Laura Battista